Home > Financial Ratios > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 19.2274.142.1834.63-12.08

What is the latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES ?

The latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES is 19.22 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202419.22
Mar202374.14
Mar20222.18
Mar202134.63
Mar2020-12.08

How is Core EBITDA Growth of DR REDDYS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 19.22
-74.08
Mar2023 74.14
3,300.92
Mar2022 2.18
-93.70
Mar2021 34.63
Positive
Mar2020 -12.08 -

Other Financial Ratios of DR REDDYS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DR REDDYS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES ₹106,957.6 Cr 1.1% -2.6% 19.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,604.0 Cr 0.1% -4% 52.9% Stock Analytics
DIVIS LABORATORIES ₹157,639.0 Cr 0.7% -0% 70.9% Stock Analytics
CIPLA ₹128,549.0 Cr 0.5% -1.7% 29.4% Stock Analytics
MANKIND PHARMA ₹106,527.0 Cr -2.8% -0.7% 52% Stock Analytics
ZYDUS LIFESCIENCES ₹97,468.9 Cr -3.6% -8.4% 62.9% Stock Analytics


DR REDDYS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES

1.1%

-2.6%

19.2%

SENSEX

-0.3%

-2.4%

22.4%


You may also like the below Video Courses